Well, I bought a few, yesterday and today. If you look at the first quarter report things are going splendidly and guidance was confirmed.
I suspect this is sitting at a low PE compared to its peers and it has the added benefit of operating in safe jurisdictions, save perhaps Didipo but the licence has now been renewed and for many years.
